You can find several drugs that claim to help you achieve a slimmer figure, but they usually do not meet expectations.
Fortunately, it seems Pfizer is close to creating a truly effective weight-loss pill.
The Telegraph said the US pharmaceutical firm will start testing different doses of the experimental drug later this year.
Article continues after this advertisementREAD: Vibrating pill tricks you into feeling full
FEATURED STORIES TECHNOLOGY vivo launches V40 Lite with 5000mAh battery covered by 50-month warranty, starts at Php 13,999 TECHNOLOGY Galaxy Buds3 Pro: Delivering tailored sound wherever you go TECHNOLOGY Very mindful, very intuitive: ASUS’ most superior AI PC yet, the Zenbook S 14, empowers you to achieve moreMikael Dolsten, Pfizer’s outgoing chief scientific officer and president of research and development, said it will “address the present and persistent medical needs of people living with obesity.”
More info on the weight-loss pillPfizer says it is advancing development of a once-daily weight loss pill https://t.co/KXJ5DvUfBO
— Quartz (@qz) July 11, 2024The official Pfizer website calls its new weight-loss drug Danuglipron. The company designed it to be taken orally, but no health authorities have approved its use.
Article continues after this advertisementIt is a type of investigational medicine known as a GLP-1 receptor agonist. In other words, it is a drug that maintains healthy blood sugar levels by increasing insulin production.
Article continues after this advertisementDanuglipron also slows digestion and boosts the feeling of fullness after eating, which may help people lose weight.
Article continues after this advertisementNowadays, Pfizer is conducting a randomized study to test the drug’s safety and effectiveness.
At the time of writing, the weight loss pill yielded promising results: Mikael Dolsten, MD., PhD., Chief Scientific Officer & President, Pfizer Research and Development, said the following regarding Danuglipron:
Article continues after this advertisement“Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates.”
“The most advanced of them, Danuglipron, has demonstrated good efficacy in a twice-daily formulation, and we believe a once-daily formulation has the potential to have a competitive profile in the oral GLP-1 space.”
Until the weight-loss pill reaches pharmacy shelves, Ozempic will likely remain the popular choice.
The New York Times says it is diabetes medicine that the US Food and Drug Administration approved.
Subscribe to our daily newsletter
Eventuallyjiliasia casino, the FDA approved a drug called Wegovy, which has a higher dose of Ozempic’s active ingredient. Wegovy started getting public attention when Elon Musk credited his new physique to it.
TOPICS: pharmaceutical, technology READ NEXT How to try the iOS 18 and iPadOS public beta today Google Gemini helps a robot navigate an office EDITORS' PICK Party-list system: What to know ahead of 2025 polls UPDATES: 2025 elections precampaign stories Kristine gets nearer; Metro Manila, 42 other areas under Signal No. 1 Manila Water Foundation and partners underscore benefits of handwashing WPS: US missile deployment to PH key for combat readiness – US general QC Mayor Belmonte highlights social services in State of City Address MOST READ SC issues TRO vs Comelec resolution on dismissed public officials Tropical Storm Kristine slightly intensifies; Signal No. 2 in 5 areas Walang Pasok: Class suspensions on Wednesday, Oct. 23 LIVE UPDATES: Tropical Storm Kristine View comments